Sunnyvale, California, July 21, 2009
For oncology programs dedicated to enhancing patient care, the
ability to access and examine cancer trends and patterns is
important. The National Oncology Data Alliance™ (NODA), formerly
the NODB, from Elekta Impac Software is a benchmarking and
analysis database that provides information from cancer
registries, including site-specific aggregate data reports for
comparative reviews, annual reporting and access to online
reports.
With more than 2.2 million cases collected from 1985 to present,
NODA offers a broad range of data, including detailed tumor
descriptions, treatments (radiation, hormonal, chemotherapy,
biological and surgical), and survival outcomes in both
outpatient and inpatient settings. NODA also is a pre-validated
source of timely, longitudinal cancer data for population-based
research.
“Fast and easy to use, we use the NODA, for simplified access to
cancer demographics,” says Diane Skinner, CTR Cancer Data
Manager, Gibbs Regional Cancer Center. “We find the NODA support
staff to be very helpful in providing useful survival analyses
that are based on comparative data, as well as offering lung
cancer and breast cancer survival statistics on a routine
basis."
For additional information on how participation can help your
oncology practice, visit
www.impac.com/noda.
About Elekta
Elekta
is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The
company develops sophisticated, state-of-the-art tools and
treatment planning systems for radiation therapy and
radiosurgery, as well as workflow enhancing software systems
across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer
confidence to both healthcare providers and patients, Elekta
aims to improve, prolong and even save patient lives, making the
future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in
over 5,000 hospitals globally, and every day more than 100,000
patients receive diagnosis, treatment or follow-up with the help
of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. For more
information about Elekta, please visit
www.elekta.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Investor inquiries:
Stina Thorman,
Investor Relations,
Elekta AB
Tel: +46 8 587 25 437
stina.thorman@elekta.com
Link Disclaimer
|
